Related Experiment Videos

Update on the treatment of disseminated intravascular coagulation

Massimo Franchini1, Franco Manzato

  • 1Servizio di Immunoematologia e Trasfusione--Centro Emofilia, Ospedale Policlinico, Piazzale Ludovico Scuro, 37134 Verona, Italy. mfranchini@mail.univr.it

Hematology (Amsterdam, Netherlands)
|June 19, 2004
PubMed

Insights

Disseminated intravascular coagulation (DIC) involves widespread clotting and bleeding. This review covers current treatments for overt DIC and explores new therapeutic strategies based on recent pathogenesis understanding.

Area of Science:

  • Hematology
  • Pathophysiology
  • Pharmacology

Background:

  • Disseminated intravascular coagulation (DIC) is a critical condition.
  • It involves systemic activation of coagulation leading to thrombosis and hemorrhage.
  • This occurs due to fibrin formation and consumption of platelets and clotting factors.

Purpose of the Study:

  • To review current knowledge on DIC treatment.
  • To focus on standard treatments for overt DIC.
  • To highlight novel therapeutic strategies informed by recent pathogenesis insights.

Main Methods:

  • Literature review of DIC treatment.
  • Analysis of current clinical practices for overt DIC.
  • Exploration of emerging therapeutic approaches.

Main Results:

  • Current standard treatments for overt DIC are detailed.
  • Novel therapeutic strategies are presented.
  • Progress in understanding DIC pathogenesis is reflected in new treatments.

Conclusions:

  • Effective management of DIC relies on understanding its complex pathophysiology.
  • Standard treatments address overt DIC symptoms.
  • Emerging therapies offer potential for improved patient outcomes.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...